To view this email as a web page, click here.
May 21, 2019
 
Mitigation of Olanzapine-Induced Weight Gain: Not the Sami Old Thing
Promising results from a phase 2 trial of olanzapine plus samidorphan in patients with schizophrenia.
©PrazisImages/Shutterstock

Read more
 
Negative Symptoms in Schizophrenia
Effective treatment of negative symptoms remains elusive.
©IgorKisseley/Shutterstock

Read more

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.